Logica COVID-19 FHIR Profile Library IG - Local Development build (v0.13.1). See the Directory of published versions
Table of Contents
![.](tbl_spacer.png) 0 Table of Contents |
![.](tbl_spacer.png) ![.](tbl_vjoin.png) 1 Home |
![.](tbl_spacer.png) ![.](tbl_vjoin.png) 2 Logica Comparison to E ICR |
![.](tbl_spacer.png) ![.](tbl_vjoin.png) 3 Patient Demographics and Vital Signs |
![.](tbl_spacer.png) ![.](tbl_vjoin.png) 4 Case Reporting Info |
![.](tbl_spacer.png) ![.](tbl_vjoin.png) 5 Exposure Info |
![.](tbl_spacer.png) ![.](tbl_vjoin.png) 6 Signs Symptoms Diagnoses Comorbidities |
![.](tbl_spacer.png) ![.](tbl_vjoin.png) 7 Lab Profiles |
![.](tbl_spacer.png) ![.](tbl_vjoin.png) 8 Smoking Status Pregnancy Status |
![.](tbl_spacer.png) ![.](tbl_vjoin.png) 9 Exposure Questionnaire |
![.](tbl_spacer.png) ![.](tbl_vjoin.png) 10 COVID 19 Immunization |
![.](tbl_spacer.png) ![.](tbl_vjoin.png) 11 History |
![.](tbl_spacer.png) ![.](tbl_vjoin_end.png) 12 Artifacts Summary |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.1 COVID 19 Exposure Core profile |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.2 Coded Laboratory Observation Base |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.3 Laboratory Observation Base |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.4 Laboratory Observation Panel Base |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.5 Quantitative Laboratory Observation Base |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.6 UnderlyingConditionObservationParent |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.7 COVID 19 Exposure Questionnaire |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.8 COVID-19 gastrointestinal and hepatic underlying condition |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.9 COVID-19 hemoglobinopathy underlying condition |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.10 COVID-19 ICD 10 Diagnosis |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.11 COVID-19 immune underlying condition |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.12 COVID-19 Immunization |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.13 COVID 19 Vaccine Manufacturer |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.14 COVID-19 renal underlying condition |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.15 COVID-19 respiratory underlying condition |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.16 COVID-19 SNOMED Diagnosis |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.17 COVID 19 Symptoms Absent |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.18 COVID 19 Symptoms Present |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.19 COVID-19 uncategorized underlying condition |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.20 COVID-19 cardiovascular underlying condition |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.21 COVID-19 Underlying Medical Condition observation |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.22 COVID-19 immunocompromised underlying condition |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.23 COVID-19 General Underlying Conditions Absent |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.24 COVID-19 General Underlying Conditions Present |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.25 COVID-19 metabolic underlying condition |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.26 COVID-19 neurologic underlying condition |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.27 Case-Patient Report Identifying Information |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.28 Exposure Type |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.29 Influenza virus A and B RNA and SARS-CoV-2 (COVID-19) N gene panel - Respiratory specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.30 Influenza virus A and B and SARS-CoV-2 (COVID-19) identified in Respiratory specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.31 Influenza virus A and B and SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel - Respiratory specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.32 Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.33 Influenza virus A and B and SARS-CoV+SARS-CoV-2 (COVID-19) Ag panel - Upper respiratory specimen by Rapid immunoassay |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.34 Influenza virus A RNA [Presence] in Respiratory specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.35 Influenza virus B RNA [Presence] in Respiratory specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.36 Gamma interferon background [Units/volume] in Blood by Immunoassay |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.37 Gestational Age at Onset of Illness |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.38 Human coronavirus 229E+HKU1+OC43+NL63 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.39 Human coronavirus 229E RNA [Presence] in Nasopharynx by NAA with non-probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.40 Human coronavirus HKU1 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.41 Human coronavirus NL63 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.42 Human coronavirus OC43 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.43 Influenza virus A Ag [Presence] in Nasopharynx by Rapid immunoassay |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.44 Influenza virus B Ag [Presence] in Nasopharynx by Rapid immunoassay |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.45 Known Exposure |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.46 Mitogen stimulated gamma interferon [Units/volume] corrected for background in Blood |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.47 Mitogen stimulated gamma interferon [Units/volume] in Blood |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.48 Pregnancy Status |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.49 Respiratory syncytial virus RNA [Presence] in Respiratory specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.50 SARS-CoV-2 (COVID19) IgG Ab [Presence] in DBS by Immunoassay |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.51 SARS-CoV-2 (COVID19) Ab [Units/volume] in Serum or Plasma by Immunoassay |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.52 SARS-CoV-2 (COVID19) IgA Ab [Presence] in Serum, Plasma, or Blood by Rapid imunoassay |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.53 SARS-CoV-2 (COVID19) IgA + IgM [Presence] in Serum or Plasma by Immunoassay |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.54 SARS-CoV-2 (COVID19) Ab [Presence] in Serum or Plasma by Immunoassay |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.55 SARS-CoV-2 (COVID19) Ag [Presence] in Respiratory specimen by Rapid immunoassay |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.56 SARS-CoV-2 (COVID19) E gene [Presence] in Respiratory specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.57 SARS-CoV-2 (COVID19) E gene [Presence] in Serum or Plasma by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.58 SARS-CoV-2 (COVID19) N gene [Presence] in Nasopharynx by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.59 SARS-CoV-2 (COVID19) N gene [Presence] in Respiratory specimen by Nucleic acid amplification using CDC primer-probe set N1 |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.60 SARS-CoV-2 (COVID19) N gene [Presence] in Respiratory specimen by Nucleaic acid amplification using CDC primer-probe set N2 |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.61 SARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by Nucleic acid amplification using CDC primer-probe set N1 |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.62 SARS-CoV-2 (COVID19) N gene [Presence] in Serum or Plasma by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.63 SARS-CoV-2 (COVID19) N gene [Presence] in Unspecified specimen by Nucleic acid amplification using primer-probe set N1 |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.64 SARS-CoV-2 (COVID19) N gene [Presence] in Unspecified specimen by Nucleic acid amplification using primer-probe set N2 |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.65 SARS-CoV-2 (COVID19) N gene [Cycle Threshold #] in Unspecified specimen by Nucleic acid amplification using primer-probe set N1 |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.66 SARS-CoV-2 (COVID19) N gene [Cycle Threshold #] in Unspecified specimen by Nucleic acid amplification using primer-probe set N2 |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.67 SARS-CoV-2 (COVID19) ORF1ab region [Presence] in Respiratory specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.68 SARS-CoV-2 (COVID19) [Presence] in Unspecified specimen by Organism specific culture |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.69 SARS-CoV-2 (COVID19) RNA [Cycle Threshold#] in Respiratory specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.70 SARS-CoV-2 (COVID19) RNA [Log#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.71 SARS-Cov-2 (COVID19) RNA panel - Unspecified specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.72 Sars-CoV-2 (COVID19) RNA [Presence] in Nasopharynx by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.73 SARS-CoV-2 (COVID19) RNA [Presence] in Saliva (oral fluid) by NAA with probe |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.74 SARS-CoV-2 (COVID19) RNA [Presence] in Saliva (oral fluid) by Sequencing |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.75 SARS-CoV-2 (COVID19) RNA [Cycle Threshold#] in Unspecified specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.76 SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Lower respiratory specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.77 SARS-CoV-2 (COVID19) S gene [Presence] in Serum or Plasma by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.78 SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel - Respiratory specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.79 SARS-CoV-2 (COVID-19) specific TCRB gene rearrangements [Presence] in Blood by Sequencing |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.80 SARS-CoV-2 (COVID-19) S protein RBD neutralizing antibody [Presence] in Serum or Plasma by Immunoassay |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.81 SARS CoV-2 stimulated gamma interferon release by T-cells [Units/volume] corrected for background in Blood |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.82 SARS CoV-2 stimulated gamma interferon release by T-cells [Units/volume] in Blood |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.83 SARS-coV-2 (COVID19) whole genome [Nucleiotide sequence] in Isolate by Sequencing |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.84 SARS-CoV + SARS-Cov-2 (COVID19) Ag [Presence] in Respiratory specimen by Rapid immunoassay |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.85 SARS-like coronavirus N gene [Presence] in Unspecified specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.86 SARS-like coronavirus N gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.87 SARS-related coronavirus RNA [Presence] in Respiratory specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.88 SARS-CoV-2 (COVID19) IgA Ab [Units/volume] in Serum or Plasma by Immunoassay |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.89 SARS-CoV-2 (COVID19) IgA Ab [Presence] in Serum or Plasma by Immunoassay |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.90 SARS-CoV-2 (COVID-19) IgA Ab [Titer] in Serum or Plasma by Immunofluorescence |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.91 SARS-CoV-2 (COVID19) IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.92 SARS-CoV-2 (COVID-19) IgG+IgM Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.93 SARS-CoV-2 (COVID19) IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.94 SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.95 SARS-CoV-2 (COVID19) IgG Ab [Presence] in Serum or Plasma by Immunoassay |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.96 SARS-CoV-2 (COVID-19) IgG Ab [Titer] in Serum or Plasma by Immunofluorescence |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.97 SARS-CoV-2 (COVID19) IgG and IgM panel - Serum or Plasma Qualitative by Rapid immunoassay |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.98 SARS-CoV-2 (COVID19) IgG and IgM panel - Serum or Plasma by Immunoassay |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.99 SARS-CoV-2 (COVID19) IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.100 SARS-CoV-2 (COVID-19) IgM Ab [Presence] in DBS by Immunoassay |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.101 SARS-CoV-2 (COVID19) IgM Ab [Presence] in Serum or Plasma by Immunoassay |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.102 SARS-CoV-2 (COVID19) IgM Ab [Presence] in Serum or Plasma by Rapid immunoassay |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.103 SARS-CoV-2 (COVID-19) IgM Ab [Titer] in Serum or Plasma by Immunofluorescence |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.104 SARS-CoV-2 (COVID19) Ab [Interpretation] in Serum or Plasma |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.105 SARS-CoV-2 (COVID-19) neutralizing antibody [Presence] in Serum by pVNT |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.106 SARS-CoV-2 (COVID-19) neutralizing antibody [Titer] in Serum by pVNT |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.107 SARS-CoV-2 (COVID-19) Ab [Presence] in DBS by Immunoassay |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.108 SARS-CoV-2 (COVID-19) Ab panel - DBS by Immunoassay |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.109 SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.110 SARS-CoV-2 (COVID19) E gene [Presence] in Unspecified specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.111 SARS-CoV-2 (COVID19) E gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.112 SARS-CoV-2 (COVID-19) N gene [Log #/volume] (viral load) in Respiratory specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.113 SARS-CoV-2 (COVID-19) N gene [#/volume] (viral load) in Respiratory specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.114 SARS-CoV-2 (COVID-19) N gene [Presence] in Nose by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.115 SARS-CoV-2 (COVID19) N gene [Presence] in Respiratory specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.116 SARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.117 SARS-CoV-2 (COVID19) N gene [Presence] in Unspecified specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.118 SARS-CoV-2 (COVID19) N gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.119 SARS-CoV-2 (COVID19) ORF1ab region [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.120 SARS-CoV-2 (COVID-19) ORF1ab region [Presence] in Saliva (oral fluid) by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.121 SARS-CoV-2 (COVID19) ORF1ab region [Presence] in Unspecified specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.122 SARS-CoV-2 (COVID19) ORF1ab region [Cycle Threshold #] in Respiratory specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.123 SARS-CoV-2 (COVID19) RNA panel - Respiratory specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.124 SARS-CoV-2 (COVID-19) RNA [Presence] in Nose by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.125 SARS-CoV-2 (COVID19) RNA [Presence] in Nasopharynx by NAA with non-probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.126 SARS-CoV-2 (COVID19) RNA [Presence] in Respiratory specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.127 SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory specimen by NAA with non-probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.128 SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory specimen by Sequencing |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.129 SARS-CoV-2 (COVID19) RNA [Presence] in Serum or Plasma by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.130 SARS-CoV-2 (COVID19) RNA [Presence] in Unspecified specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.131 SARS-CoV-2 (COVID-19) RNA panel - Saliva (oral fluid) by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.132 SARS-CoV-2 (COVID19) RdRp gene [Presence] in Respiratory specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.133 SARS-CoV-2 (COVID19) RdRp gene [Presence] in Unspecified specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.134 SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Upper respiratory specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.135 SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Saliva (oral fluid) by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.136 SARS-CoV-2 (COVID19) RdRp gene [Cycle Threshold #] in Respiratory specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.137 SARS-CoV-2 (COVID19) RdRp gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.138 SARS-CoV-2 (COVID19) S gene [Presence] in Respiratory specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.139 SARS-CoV-2 (COVID-19) S gene [Presence] in Respiratory specimen by Sequencing |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.140 SARS-CoV-2 (COVID19) S gene [Presence] in Unspecified specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.141 SARS-CoV-2 (COVID19) S gene [Cycle Threshold #] in Respiratory specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.142 SARS-CoV-2 (COVID19) S gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.143 SARS CoV-2 stimulated gamma interferon [Presence] in Blood |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.144 SARS CoV-2 stimulated gamma interferon panel - Blood |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.145 SARS-related coronavirus+MERS coronavirus RNA [Presence] in Respiratory specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.146 SARS-related coronavirus E gene [Presence] in Saliva (oral fluid) by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.147 SARS-related coronavirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.148 SARS-related coronavirus E gene [Presence] in Lower respiratory specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.149 SARS-related coronavirus E gene [Presence] in Upper respiratory specimen by NAA with probe detection |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.150 Tobacco smoking status |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.151 Travel History |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.152 COVID-19 Underlying Condition Code |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.153 COVID-19 Underlying Condition Reference |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.154 Certainty of Absence |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.155 Certainty of Presence |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.156 Procedure Code |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.157 Reporting Priority |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.158 Antibody Not Detected, Past/Recent Infection LOINC answer value set. |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.159 COVID-19 cardiovascular underlying condition reference set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.160 COVID-19 Disease Severity Value Set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.161 COVID-19 ICD 10 Diagnosis Value Set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.162 COVID-19 SNOMED CT Diagnosis Value Set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.163 COVID-19 Signs and Symptoms Severity Value Set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.164 COVID-19 Signs and Symptoms Value Set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.165 COVID-19 uncategorized underlying condition reference set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.166 COVID-19 gastrointestinal or hepatic underlying condition reference set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.167 COVID-19 hemoglobinopathy underlying condition reference set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.168 COVID-19 immune underlying condition reference set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.169 COVID-19 immunocompromised underlying condition reference set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.170 COVID-19 Underlying Medical Condition Value Set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.171 COVID-19 metabolic underlying condition reference set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.172 COVID-19 neurologic underlying condition reference set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.173 COVID-19 renal underlying condition reference set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.174 COVID-19 respiratory underlying condition reference set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.175 COVID 19 Vaccine Procedure Code value set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.176 COVID 19 CVX Code System Vaccine Codes |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.177 Certainty of Absence Value Set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.178 Certainty of Presence Value Set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.179 Close Contact Setting Value Set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.180 Country Codes Value Set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.181 Detected, Not Detected, Inconclusive Value Set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.182 Detected, Not-detected, Equivocal, Invalid value set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.183 Detected, Not-detected Value Set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.184 Detected, Not-detected, Inconclusive, Invalid value set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.185 Detected, Not-detected value set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.186 Influenza A, Influenza B, SARS CoV 2, and SARS CoV value set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.187 Influenza A, Influenza B, and SARS CoV2 value set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.188 HL7 Yes/No value set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.189 Healthcare Occupation Value Set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.190 ISO Code System 3166 country codes |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.191 ISO Code System 3166 state/province codes. |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.192 Known Exposure LOINC Answer Value Set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.193 Positive/Negative Value Set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.194 COVID19 Positive, Negative, Indeterminate value set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.195 COVID19 Positive Negative Invalid value set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.196 COVID19 Positive Negative Suspected Invalid value set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.197 Positive, Negative value set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.198 Pregnancy Status Value Set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.199 Present, Absent, Unknown Value Set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.200 Reactive - Non-reactive value set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.201 COVID19 Reactive, Non-reactive, Invalid value set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.202 COVID19 Reactive Non-reactive value set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.203 Reporting Priorities Value Set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.204 Smoking Status Value Set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.205 State Codes Value Set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.206 Yes/No Value Set |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 12.207 COVID19 Undefined Lab Values code system |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin_end.png) 12.208 COVID19 Underlying Condition Category Code System |